Reported Earnings • 17h
Full year 2026 earnings released: US$6.92 loss per share (vs US$12.75 loss in FY 2025) Full year 2026 results: US$6.92 loss per share (improved from US$12.75 loss in FY 2025). Revenue: US$5.37m (up 28% from FY 2025). Net loss: US$4.94m (loss narrowed 3.1% from FY 2025). New Risk • Jun 23
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 46% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 31% per year over the past 5 years. Shareholders have been substantially diluted in the past year (46% increase in shares outstanding). Market cap is less than US$10m (US$4.66m market cap). Minor Risk Revenue is less than US$5m (US$4.3m revenue). Ankündigung • Mar 30
Addentax Group Corp. (NasdaqCM:ATXG) completed the acquisition of 62.18% stake in KEEMO Fashion Group Limited (OTCPK:KMFG) from Guang Wen Global Group Limited. Addentax Group Corp. (NasdaqCM:ATXG) agreed to acquire 62.18% stake in KEEMO Fashion Group Limited (OTCPK:KMFG) from Guang Wen Global Group Limited for $5.5 million on February 17, 2026. As per the transaction, Addentax Group Corp. will acquire 34.2 million shares and shall split and transfer a portion, approximately $5.5 million, of an existing bond to Guang Wen Global Group Limited as consideration for the acquisition.
The expected completion of the transaction is May 1, 2026.
Lawrence S. Venick of Loeb & Loeb LLP acted as legal advisor for Guang Wen Global Group Limited.
Addentax Group Corp. (NasdaqCM:ATXG) completed the acquisition of 62.18% stake in KEEMO Fashion Group Limited (OTCPK:KMFG) from Guang Wen Global Group Limited on March 30, 2026. New Risk • Mar 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 31% per year over the past 5 years. Market cap is less than US$10m (US$3.88m market cap). Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Revenue is less than US$5m (US$4.3m revenue). Ankündigung • Feb 19
Addentax Group Corp. (NasdaqCM:ATXG) agreed to acquire 62.18% stake in KEEMO Fashion Group Limited (OTCPK:KMFG) from Guang Wen Global Group Limited for $5.5 million. Addentax Group Corp. (NasdaqCM:ATXG) agreed to acquire 62.18% stake in KEEMO Fashion Group Limited (OTCPK:KMFG) from Guang Wen Global Group Limited for $5.5 million on February 17, 2026. As per the transaction, Addentax Group Corp. will acquire 34.2 million shares and shall split and transfer a portion, approximately $5.5 million, of an existing bond to Guang Wen Global Group Limited as consideration for the acquisition.
The expected completion of the transaction is May 1, 2026.
Lawrence S. Venick of Loeb & Loeb LLP acted as legal advisor for Guang Wen Global Group Limited. Reported Earnings • Feb 16
Third quarter 2026 earnings released: US$0.45 loss per share (vs US$0.19 loss in 3Q 2025) Third quarter 2026 results: US$0.45 loss per share (further deteriorated from US$0.19 loss in 3Q 2025). Revenue: US$975.8k (down 7.9% from 3Q 2025). Net loss: US$4.20m (loss widened 287% from 3Q 2025). Ankündigung • Feb 11
Addentax Group Corp. announced that it expects to receive $200 million in funding Addentax Group Corp announced a strategic equity investment with two institutional investors backed by a Middle Eastern royal family to issue 133,333,333 common shares at an issue price of $1.5 for the proceeds of $199,999,999.5 on February 10, 2026. Transaction is expected to close within six months. Transaction is subject to approval of regulatory authority and stock exchange. Ankündigung • Dec 09
Addentax Group Corp., Annual General Meeting, Jan 30, 2026 Addentax Group Corp., Annual General Meeting, Jan 30, 2026. Reported Earnings • Nov 16
Second quarter 2026 earnings released: US$0.11 loss per share (vs US$0.14 loss in 2Q 2025) Second quarter 2026 results: US$0.11 loss per share. Revenue: US$820.7k (down 39% from 2Q 2025). Net loss: US$831.9k (loss widened 15% from 2Q 2025). Buy Or Sell Opportunity • Oct 20
Now 20% undervalued Over the last 90 days, the stock has risen 40% to US$0.94. The fair value is estimated to be US$1.18, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 35% over the last 3 years. Meanwhile, the company became loss making. Ankündigung • Oct 08
Addentax Group Corp. Announces Notice of Nasdaq Continued Listing Non-Compliance and Extension Period As previously disclosed, Addentax Group Corp. received a notice dated April 9, 2025, from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its common stock, par value $0.001 per share (the “Common Stock”), was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq granted the Company 180 days, or until October 6, 2025, to regain compliance with the Minimum Bid Price Rule. In order to regain compliance, the closing bid price of the Common Stock must be at least $1 per share for a minimum of 10 consecutive business days during this 180-day period. Although the Company’s closing bid price had been above the minimum requirement for ten consecutive trading days prior to October 6, 2025, the Nasdaq determined that the Company had not regained compliance with the Minimum Bid Price Rule as of that date. However, the Staff determined that the Company was eligible for an additional 180-day period, or until April 6, 2026, to regain compliance. The Staff’s determination was based on (i) our meeting the continued listing requirement for market value of our publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Rule, and (ii) our providing written notice to Nasdaq of our intent to cure the deficiency during this second compliance period, if necessary by effecting a reverse stock split. If at any time during this second 180-day period the closing bid price of the Company’s Common Stock is at least $1 per share for at least a minimum of 10 consecutive business days, the Staff have stated that they will provide written confirmation of compliance. If compliance cannot be demonstrated by April 6, 2026, the Staff will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal the Staff’s determination to a hearings panel. The Company is diligently working to regain compliance with the Minimum Bid Price Rule. There can be no assurance, however, of the Company’s ability to maintain compliance with the Minimum Bid Price Rule once compliance therewith is regained or maintain compliance with any other Nasdaq listing requirements. Buy Or Sell Opportunity • Sep 23
Now 20% undervalued Over the last 90 days, the stock has risen 70% to US$1.01. The fair value is estimated to be US$1.26, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 35% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Aug 15
First quarter 2026 earnings released: US$0.061 loss per share (vs US$0.25 loss in 1Q 2025) First quarter 2026 results: US$0.061 loss per share (improved from US$0.25 loss in 1Q 2025). Revenue: US$981.0k (up 15% from 1Q 2025). Net loss: US$392.4k (loss narrowed 68% from 1Q 2025). Reported Earnings • Jun 30
Full year 2025 earnings released: US$0.85 loss per share (vs US$0.71 loss in FY 2024) Full year 2025 results: US$0.85 loss per share (further deteriorated from US$0.71 loss in FY 2024). Revenue: US$4.18m (down 19% from FY 2024). Net loss: US$5.09m (loss widened 64% from FY 2024). Ankündigung • Apr 23
Addentax Group Receives A Letter from the Listings Qualifications Department of the Nasdaq Stock Market Addentax Group Corp. received a letter dated April 9, 2025 from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its common stock was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Nasdaq letter does not result in the immediate delisting of the Company’s shares of common stock, and the shares will continue to trade uninterrupted under the symbol “ATXG.” Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of one hundred eighty (180) calendar days, or until October 6, 2025 (the “Compliance Period”), to regain compliance with the Minimum Bid Price Rule. If at any time during the Compliance Period, the closing bid price per share of the Company’s common stock is at least $1.00 for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance by the end of the Compliance Period, the Company may be eligible for an additional 180 calendar day grace period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split, if necessary. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten (10) business days prior to the end of the Compliance Period, or the end of the second compliance period if granted. Ankündigung • Mar 11
Addentax Group Corp., Annual General Meeting, Mar 31, 2025 Addentax Group Corp., Annual General Meeting, Mar 31, 2025. Ankündigung • Mar 03
Addentax Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement Addentax Group Corp. announced that it has regained compliance with the Nasdaq Listing Rule 5450(a)(1). On April 24, 2024, the Company was notified by Nasdaq that its common stock had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days, as required by Nasdaq Listing Rules. However, Nasdaq has now confirmed that for the 10 consecutive business days from February 7 through February 21, 2025, the closing bid price of the Company's common stock has been at or above $1.00 per share. As a result, the Company has regained compliance, and this matter is now closed. Reported Earnings • Feb 16
Third quarter 2025 earnings released: US$0.19 loss per share (vs US$0.66 loss in 3Q 2024) Third quarter 2025 results: US$0.19 loss per share (improved from US$0.66 loss in 3Q 2024). Revenue: US$1.06m (down 28% from 3Q 2024). Net loss: US$1.09m (loss narrowed 58% from 3Q 2024). New Risk • Jan 15
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Market cap is less than US$10m (US$4.29m market cap). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (US$5.0m revenue). Reported Earnings • Nov 17
Second quarter 2025 earnings released: US$0.14 loss per share (vs US$0.37 profit in 2Q 2024) Second quarter 2025 results: US$0.14 loss per share (down from US$0.37 profit in 2Q 2024). Revenue: US$1.34m (flat on 2Q 2024). Net loss: US$721.5k (down 153% from profit in 2Q 2024). Ankündigung • Oct 24
Addentax Group Receives Notice from Nasdaq As previously disclosed, Addentax Group Corp. received a notice dated April 24, 2024, from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its common stock, par value $0.001 per share (the “Common Stock”), was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq granted the Company 180 days, or until October 21, 2024, to regain compliance with the Minimum Bid Price Rule. In order to regain compliance, the closing bid price of the Common Stock must be at least $1 per share for a minimum of 10 consecutive business days during this 180-day period. The Company’s Common Stock has not regained compliance with the Minimum Bid Price Rule as of that date. By letter dated October 21, 2024, the Company requested an additional 180-day extension in which to regain compliance. On October 22, 2024, the Company received notice from Nasdaq indicating that, while the Company has not regained compliance with the Minimum Bid Price Rule, the Staff has determined that the Company is eligible for an additional 180-day period, or until April 21, 2025, to regain compliance. The Staff’s determination was based on (i) our meeting the continued listing requirement for market value of our publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the Minimum Bid Price Rule, and (ii) our providing written notice to Nasdaq of our intent to cure the deficiency during this second compliance period, if necessary by effecting a reverse stock split. If at any time during this second 180-day period the closing bid price of the Company’s Common Stock is at least $1 per share for at least a minimum of 10 consecutive business days, the Staff have stated that they will provide written confirmation of compliance. If compliance cannot be demonstrated by April 21, 2025, the Staff will provide written notification that the Company’s securities will be delisted. At that time, the Company may appeal the Staff’s determination to a hearings panel. The Company is diligently working to regain compliance with the Minimum Bid Price Rule and has already received stockholder approval to effect a reverse stock split, if necessary, to regain compliance therewith. There can be no assurance, however, of the Company’s ability to maintain compliance with the Minimum Bid Price Rule once compliance therewith is regained or maintain compliance with any other Nasdaq listing requirements. Ankündigung • Jun 30
Addentax Group Corp. announced delayed annual 10-K filing On 06/28/2024, Addentax Group Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Ankündigung • May 23
Addentax Group Corp., Annual General Meeting, Jun 28, 2024 Addentax Group Corp., Annual General Meeting, Jun 28, 2024. New Risk • Apr 30
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 52% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Market cap is less than US$10m (US$5.46m market cap). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Ankündigung • Apr 30
Addentax Group Corp. announced that it has received $0.6468 million in funding Addentax Group Corp. announced that it has entered into two Private Placement Agreements with certain individual investors who are independent third parties, pursuant to which the Company issued to each of the investor 330,000 shares of its common stock, par value $0.001 per share at an issue price of $0.98 per share for the aggregate gross proceeds of $646,800 on April 29, 2024. The Agreement contains customary representations, warranties, covenants, conditions and indemnities for agreements of this type. The company will issue securities pursuant to exemption provided under Regulation D from 2 investors. Ankündigung • Apr 27
Addentax Group Corp. Receives A Notice from the Listings Qualifications Department of the Nasdaq Stock Market LLC Regarding Minimum Bid Price Addentax Group Corp. received a notice dated April 24, 2024, from the Listings Qualifications Department (the Staff") of The Nasdaq Stock Market LLC (Nasdaq") notifying the Company that the minimum bid price per share of its ordinary shares was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set in Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Rule"). The Nasdaq notification letter does not result in the immediate delisting of the Company's ordinary shares, and the shares will continue to trade uninterrupted under the symbol ATXG." Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of one hundred eighty (180) calendar days, or until October 21, 2024 (the Compliance Period"), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per share of the Company's ordinary shares is at least $1.00 for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance by October 21, 2024, the Company may be eligible for an additional 180 calendar day grace period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split, if necessary. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten (10) business days prior to October 21, 2024, or the expiration of the second compliance period if granted. This information is being provided solely to comply with NASDAQ Listing Rules requiring public announcement of the Company's receipt of the letter from NASDAQ. Ankündigung • Apr 03
Addentax Group Receives Written Notice from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5620(a) for Continued Listing on The Nasdaq Capital Market On April 1, 2024, the Addentax Group Corp. (the ‘Company’) received a written notice from the Listing Qualifications department of The Nasdaq Stock Market stating that because the Company has not yet held an annual meeting of shareholders within 12 months of the end of the Company’s fiscal year end, and it no longer complies with Nasdaq Listing Rule 5620(a) for continued listing on The Nasdaq Capital Market. The Company has 45 calendar days from the date of the notice, to submit a plan to regain compliance and, if Nasdaq accepts the plan, it may grant an exception of up to 180 calendar days from the fiscal year end, or until September 27, 2024, to regain compliance. The Company intends to submit a compliance plan within the specified period, which it expects will consist of holding an annual meeting of stockholders. While the compliance plan is pending, the Company’s securities will continue to trade on NASDAQ. Reported Earnings • Feb 16
Third quarter 2024 earnings released: US$0.66 loss per share (vs US$0.029 loss in 3Q 2023) Third quarter 2024 results: US$0.66 loss per share (further deteriorated from US$0.029 loss in 3Q 2023). Revenue: US$1.47m (down 31% from 3Q 2023). Net loss: US$2.61m (loss widened US$2.53m from 3Q 2023). Reported Earnings • Nov 17
Second quarter 2024 earnings released: EPS: US$0.37 (vs US$0.031 in 2Q 2023) Second quarter 2024 results: EPS: US$0.37 (up from US$0.031 in 2Q 2023). Revenue: US$1.34m (down 38% from 2Q 2023). Net income: US$1.36m (up US$1.28m from 2Q 2023). Ankündigung • Aug 30
Addentax Group Regains Compliance with Nasdaq Minimum Bid Price Requirement Addentax Group Corp. announced that it has regained compliance with Nasdaq's minimum bid price listing requirement. A written notice from Listing Qualifications Staff of Nasdaq Stock Market LLC on July 17, 2023, indicated that as of July 14, 2023, the minimum bid price of the Company's common stock was $1.00 per share or greater for the last 10 consecutive business days. As a result, the Company has now regained compliance with Listing Rule 5550(a)(2) and the matter is now closed. New Risk • Aug 20
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 65% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (65% increase in shares outstanding). Market cap is less than US$10m (US$9.28m market cap). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change). Ankündigung • Aug 17
Addentax Group Corp. Continues to Make Significant Strides in Advancing the Automation of Artificial Intelligence Internet Operational Tools Addentax Group Corp. has announced significant progress in its collaborative initiative with Games-as-a-Service (GaaS) firms for the development of Artificial Intelligence ("AI") Online Operational Tools (referred to as the AI project), which was launched on June 30, 2023. This advancement signifies a substantial step forward in Addentax's venture into AI innovation. The AI project team has been engaging in strategic discussions with three venture capital firms from the United States and Europe. These discussions, spanning several weeks, have generated substantial enthusiasm within the Venture Capital firms, highlighting the potential inherent in the implementation and commercialization of the AI project in the dynamic landscape of online gaming. In parallel, the AI project team is in the final stages of negotiating a collaborative partnership with an online gaming enterprise based in the United States. This partnership emphasizes the industry's recognition of the transformative capabilities of the AI project. The upcoming integration of the AI project team's innovative tools and products into this gaming enterprise's ecosystem represents a significant step towards enhancing operational efficiency and enriching the user experience. The AI project is set for the imminent launch of its prototype in September 2023, which is aimed at optimizing commercialization strategies and facilitating insightful big data analyses. Furthermore, this debut will be swiftly followed by the introduction of advanced functionalities, including real-time content updates and sustainable profitability enhancements. New Risk • Aug 16
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.09m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (US$9.09m market cap). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (43% increase in shares outstanding). Reported Earnings • Aug 16
Full year 2023 earnings released: EPS: US$0.43 (vs US$0.029 in FY 2022) Full year 2023 results: EPS: US$0.43 (up from US$0.029 in FY 2022). Revenue: US$7.94m (down 37% from FY 2022). Net income: US$1.32m (up US$1.24m from FY 2022). Profit margin: 17% (up from 0.6% in FY 2022). Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to US$2.43, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 15x in the Logistics industry in the US. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to US$3.78, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 15x in the Logistics industry in the US. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment deteriorates as stock falls 29% After last week's 29% share price decline to US$4.60, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 15x in the Logistics industry in the US. Ankündigung • Jul 01
Addentax Group Corp. Launches Automation of Artificial Intelligence Internet Operational Tools Project with Top Games-as-a-Service Firms Addentax Group Corp. announced that it has formed a cooperation leading certain Games-as-a-Service ("GaaS") firms to launch a project focusing on the development of Artificial Intelligence ("AI") Online Operational Tools (the "AI project"). As the technological landscape rapidly evolves and AI continues to assert its influence across a diverse range of sectors, Addentax is prepared to expand its business portfolio by embracing the transformative potential of AI. The AI project primarily centres around the implementation of AI Online Operational Tools, which are vital in the continual refinement and update of content within online games. These tools equip gaming companies to optimize their commercialisation strategies, creating sustainable profitability. AI Online Operational Tools has delivered substantial revenue growth in popular games. The AI project is driven by a seasoned management and development team, comprised of experienced professionals with extensive experiences in AI and gaming from the cooperating leading GaaS firms. The team members have held prominent positions at esteemed companies like Tencent Holdings Limited, LinkedIn Corporation, and Responsawn Entertainment LLC. Their collective expertise spans various industries and fields, including but not limited to game developments, AI language modelling, and successful commercialisation of AI tools, positioning them as key innovators in the industry. Reported Earnings • Jun 30
Full year 2023 earnings released: EPS: US$0.043 (vs US$0.003 in FY 2022) Full year 2023 results: EPS: US$0.043 (up from US$0.003 in FY 2022). Revenue: US$7.94m (down 37% from FY 2022). Net income: US$1.32m (up US$1.24m from FY 2022). Profit margin: 17% (up from 0.6% in FY 2022). Ankündigung • Jun 21
Addentax Group Receives a Notice from Nasdaq Notifying the Company Did Not Meet the Minimum Bid Price Requirement Set in Nasdaq Listing Rule 5550(a)(2) Addentax Group Corp. received a notice dated June 15, 2023, from the Listings Qualifications Department (the Staff") of The Nasdaq Stock Market LLC (Nasdaq") notifying the Company that the minimum bid price per share ofits common stock was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set in Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Rule"). The Nasdaq notification letter does not result in the immediate delisting of the Company's common stock, and the shares will continue to trade uninterrupted under the symbol ATXG." Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of one hundred eighty (180) calendar days, or until December 12, 2023 (the Compliance Period"), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per share of the Company's common stock is at least $1.00 for a minimum of ten (10) consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance by December 12, 2023, the Company may be eligible for an additional 180 calendar day grace period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split, if necessary. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten (10) business days prior to December 12, 2023, or the expiration of the second compliance period if granted. Ankündigung • Jun 17
Addentax Group in Advanced Talks to Acquire Partial Stake in Shanghai Bao Pharmaceutical Addentax Group Corp. (NasdaqCM:ATXG) announced that it is in advanced discussion with its Company's Chairman and Chief Executive Officer, Mr. Hong Zhida, to acquire Mr. Hong's partial stake in Shanghai Bao Pharmaceutical Company Limited ("Bao Pharma"), via Shenzhen Grandway Capital Management Co., Ltd. ("Grandway Capital). Grandway Capital will act as a fund manager. Mr. Hong invested in Bao Pharma, via Grandway Capital in 2020. On August 25, 2022, Bao Pharma received USD 100 million in a round of funding led by Shenzhen Oriental Fortune Capital Co., Ltd. The transaction included participation from Finnova Capital, Haitong Innovation Private Fund Management Co., Ltd., Shanghai Sun Rock Capital Management Co., Ltd., Center Laboratories Inc. Mr. Zhida Hong, the Chairman and Chief Executive Officer of Addentax, stated, "Our group is now aggressively diversifying its business to other cutting edge areas, including biotech and electric vehicles etc. In addition to our traditional garment and logistics businesses, I believe that our new venture will soon generate extra revenue to this group and maximize the shareholders' interests". Reported Earnings • Feb 16
Third quarter 2023 earnings released: US$0.003 loss per share (vs US$0 in 3Q 2022) Third quarter 2023 results: US$0.003 loss per share (further deteriorated from US$0 in 3Q 2022). Revenue: US$2.12m (down 24% from 3Q 2022). Net loss: US$82.2k (down US$93.8k from profit in 3Q 2022). Ankündigung • Jan 05
Addentax Group Corp. announced that it has received $15 million in funding Addentax Group Corp. announced that it has entered into agreement with certain accredited investors for a private placement of senior secured convertible notes for proceeds of $15,000,000 on January 4, 2023. The company will issue two senior secured convertible notes at an original principal amount of $8,333,333.33 for aggregate gross proceeds of $16,666,666.66. The company issued convertible notes at an original discount of 10%. The notes bears interest rate of 5% per annum, and the Company will be required to pay installment amounts, or at its option redeem such amounts under the Notes each month commencing on the last trading day of the calendar month in which the control account trigger date occurs, and thereafter, the last trading day of each calendar month until the maturity date of July 4, 2024, at which time all outstanding amounts remaining, if any, will be due and payable in full. he Convertible Notes are convertible into shares of Common Stock, beginning after the original date of issuance at an initial conversion price of $1.25 per share. The company also issued warrants to purchase up to 16,077,172 shares of common shares at an exercise price of $1.25 per share. The Notes, Warrants, and the shares issuable upon the conversion of the Notes and the exercise of the Warrants are offered and sold pursuant to exemptions from the registration requirements of the Securities Act afforded by Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder. Reported Earnings • Nov 19
Second quarter 2023 earnings released: EPS: US$0.003 (vs US$0.001 in 2Q 2022) Second quarter 2023 results: EPS: US$0.003 (up from US$0.001 in 2Q 2022). Revenue: US$2.14m (down 22% from 2Q 2022). Net income: US$83.2k (up 160% from 2Q 2022). Profit margin: 3.9% (up from 1.2% in 2Q 2022). The increase in margin was driven by lower expenses. Buying Opportunity • Oct 20
Now 23% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be US$3.18, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Sep 30
Now 23% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be US$3.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable. Ankündigung • Sep 01
Addentax Group Common Stock Deleted from OTC Equity Addentax Group Corp. Common Stock has been deleted from OTC Equity effective from August 31, 2022, due to Market Center Change Listed on NASDAQ.